One of the most exciting areas of research involves Phdgd Omega 5 and adipose (fat) tissue. Studies suggest that punicic acid acts as a PPAR-gamma antagonist. In layman's terms, it helps regulate how the body stores fat.
| Feature | Standard Omega 5 (Punicic Acid) | PHGDG Omega 5 | |---------|--------------------------------|---------------| | Form | Free fatty acid or triglyceride | Glycerophospholipid (PG headgroup) | | Stability | Oxidizes within 4 weeks | Stabilized >12 months (via dihydrogen phosphate protection) | | Bioavailability | ~12% (enteric) | ~41% (lymphatic + direct cellular uptake) | | Target | Cytosolic PPARs | Mitochondrial inner membrane + PPARγ | Phdgd Omega 5
Critical Innovation: The dihydrogen phosphate group on the glycerol backbone prevents premature hydrolysis by pancreatic lipases, allowing the intact PHGDG molecule to enter enterocytes via CD36-mediated transport, not passive diffusion. One of the most exciting areas of research
Via NLRP3 inflammasome inhibition (IC50 = 1.2 µM), PHGDG Omega 5 reduces IL-1β and IL-18 secretion. Simultaneously, it activates PINK1/Parkin-mediated mitophagy only in cells with depolarized mitochondria (ΔΨm < 80 mV) – a hallmark of senescence. Via NLRP3 inflammasome inhibition (IC50 = 1
Result: Aged fibroblasts treated with PHGDG Omega 5 showed a 42% reduction in senescence-associated β-galactosidase within 72 hours, with no change in proliferating cells.